You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • AB1071 Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS Action) Core Laboratory Validation Exercise: Comparison of Chemiluminescence Immunoassay (CIA) and Enzyme-Linked Immunosorbant Assay (ELISA)

Article info

Article menu
Download PDFPDF
Abstracts Accepted for Publication
Diagnostics and imaging procedures
AB1071 Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS Action) Core Laboratory Validation Exercise: Comparison of Chemiluminescence Immunoassay (CIA) and Enzyme-Linked Immunosorbant Assay (ELISA)

Authors

Citation

Bertolaccini M, Willis R, Lakos G on behalf of APS ACTION , et al
AB1071 Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS Action) Core Laboratory Validation Exercise: Comparison of Chemiluminescence Immunoassay (CIA) and Enzyme-Linked Immunosorbant Assay (ELISA)
Annals of the Rheumatic Diseases 2015;74:1258.

Publication history

  • First published June 9, 2015.
Online issue publication 
April 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2015, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions